Mater Medical Research Institute researchers have an active and successful research program which aims to characterise the molecular mechanisms controlling adipogenesis. The researchers have now identified additional control factors, which they have begun to assess for therapeutic potential. The development of technology to modulate these pathways is expected to accelerate new anti-obesity pharmacotherapies for targeting adipose tissue.

Fat mass reduction and improved health outcomes would result from this non-surgical treatment for treating morbidly obese patients and also improve health outcomes for obesity-related diabetes, heart disease, hypertension, stroke, arthritis, sleep apnoea and gall bladder disease. 

• Licenceⁱ